Research & Development Microbiology, bioMérieux SA, 3 route de Port Michaud, 38 390 La-Balme-les-Grottes, France.
Bioorg Med Chem. 2011 May 1;19(9):2903-10. doi: 10.1016/j.bmc.2011.03.043. Epub 2011 Apr 8.
A series of 2-(2-nitrophenyl)benzothiazole 7, 2-(2-nitrophenyl)benzoxazole 10 and 2-(2-nitrophenyl)benzimidazole 13 derivatives have been synthesised and assessed as indicators of nitroreductase activity across a range of clinically important Gram negative and Gram positive bacteria. The majority of Gram negative bacteria produced strongly fluorescent colonies with substrates 7 and 10 whereas fluorescence production in Gram positive bacteria was less widespread. The l-alanine 16 and 19 and β-alanine 21 and 23 derivatives have been prepared from 2-(2-aminophenyl)benzothiazole 14 and 2-(2-aminophenyl)benzoxazole 17. These four compounds have been evaluated as indicators of aminopeptidase activity. The growth of Gram positive bacteria was generally inhibited by these substrates but fluorescent colonies were produced with the majority of Gram negative bacteria tested.
一系列 2-(2-硝基苯基)苯并噻唑 7、2-(2-硝基苯基)苯并恶唑 10 和 2-(2-硝基苯基)苯并咪唑 13 衍生物已经被合成,并作为硝基还原酶活性的指示剂,在一系列临床重要的革兰氏阴性和革兰氏阳性细菌中进行了评估。大多数革兰氏阴性细菌用底物 7 和 10 产生强烈荧光的菌落,而革兰氏阳性细菌的荧光产生则不那么广泛。L-丙氨酸 16 和 19 以及 β-丙氨酸 21 和 23 衍生物已由 2-(2-氨基苯基)苯并噻唑 14 和 2-(2-氨基苯基)苯并恶唑 17 制备。这四种化合物已被评估为氨肽酶活性的指示剂。这些底物通常抑制革兰氏阳性细菌的生长,但用大多数测试的革兰氏阴性细菌产生了荧光菌落。